Advance care planning in Belgium and The Netherlands: a nationwide retrospective study via sentinel networks of general practitioners by Meeussen, Koen et al.
Vol. 42 No. 4 October 2011 Journal of Pain and Symptom Management 565Original ArticleAdvance Care Planning in Belgium
and The Netherlands: A Nationwide
Retrospective Study Via Sentinel Networks
of General Practitioners
Koen Meeussen, PhD, Lieve Van den Block, PhD, Michael Echteld, PhD,
Nathalie Bossuyt, MD, Johan Bilsen, PhD, Viviane Van Casteren, MD,
Ebun Abarshi, MD, Ge Donker, MD, Bregje Onwuteaka-Philipsen, PhD,
and Luc Deliens, PhD
End-of-Life Care Research Group (K.M., L.V.d.B., J.B., L.D.), Ghent University & Vrije Universiteit
Brussel, Brussels; Departments of Public Health (J.B.) and General Practice (L.V.d.B.), Vrije
Universiteit Brussel, Brussels; Scientific Institute of Public Health, Public Health and Surveillance
(N.B., V.V.C.), Brussels, Belgium; NIVEL, Netherlands Institute for Health Services Research (G.D.),
Utrecht; and Department of Public and Occupational Health (E.A., M.E., B.O.-P., L.D.), EMGO
Institute for Health and Care Research, VU University Medical Center, Amsterdam, The NetherlandsAbstract
Context. Advance care planning (ACP) is an important part of patient-centered
palliative care. There have been fewnationwide studies of ACP, especially in Europe.
Objectives. To investigate the prevalence and characteristics of ACP in two
European countries and identify the associated factors.
Methods. A mortality follow-back study was undertaken in 2007 via
representative nationwide Sentinel Networks of general practitioners (GPs) in
Belgium and The Netherlands using similar standardized procedures. All GPs
reported on each non-suddenly deceased patient in their practice. Our main
outcome measure was whether or not ACP, that is, an agreement for medical
treatment and/or medical decisions in the last phase of life in the case of the
patient losing competence, was present.
Results. Among 1072 non-sudden deaths, ACP was done with 34% of patients
and most often related to the forgoing of potential life-prolonging treatments in
general (24%). In 8% of cases, ACP was made in consultation with the patient and
in writing. In 23% of cases, care was planned with the patient’s family only.
Multivariate analysis revealed that ACP was more often made with patients if they
were capable of decision making during the last three days of life (odds ratio [OR]
3.86; 95% confidence interval [CI] 2.4e6.1), received treatment aimed at
palliation in the last week (OR 2.57; 95% CI 1.6e4.2), had contact with a GP in the
last week (OR 2.71; 95% CI 1.7e4.1), died of cancer (OR 1.46; 95% CI 1.1e2.0),
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566 Vol. 42 No. 4 October 2011Meeussen et al.Conclusion. In these countries, ACP is done with approximately one-third
of the studied terminally ill patient population. Most agreements are made only
verbally, and care also is often planned with family only. ACP relates strongly both
to patient factors and to health care measures performed at the very end of
life. J Pain Symptom Manage 2011;42:565e577.  2011 U.S. Cancer Pain Relief
Committee. Published by Elsevier Inc. All rights reserved.Key Words
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An important aspect of the quality of end-of-
life care is the congruence between the care
and the patient’s wishes. A patient’s inability
to participate in decision making could hinder
the provision of good quality end-of-life care if
their exact preferences remained unknown.
One way of shaping future clinical care to fit
each patient’s wishes and values is by engaging
in advance care planning (ACP), a process of
communication among patients, their health
care providers, their families, and important
others regarding the kind of care that will be
considered appropriate when the patient is
unable to make decisions about his or her
care.1
With the passage of the Patient Self-
Determination Act2 in the U.S. in 1991, much
attention was given to the right of patients to
be involved in decision making. This resulted
in the formalization of advance directives,
such as living wills and the durable power of at-
torney. Research shows thatmore than a decade
after the enactment, most (71%) of those U.S.
citizens who experienced a nontraumatic death
had completed an advance directive, and this
was perceived by family members as being asso-
ciated with better quality end-of-life care.3,4
However, most of the literature suggests that
merely between 18% and 30% of the U.S. gen-
eral population have completed an advance
directive, which may be considered as a low
percentage in view of the widespread support
for ACP.5
In contrast to the research conducted in the
U.S., relatively few studies have addressed the
topic of ACP in Europe.6 Little research has
been undertaken even as the patient’s right
to self-determination concerning the end of
life has increasingly received attention in West-
ern Europe within recent decades.In this study, the prevalence and character-
istics of ACP in both Belgium and The
Netherlands were investigated. These neigh-
boring countries are situated in the center
of Western Europe and have between 100,000
(Belgium) and 135,000 (The Netherlands)
deaths annually, which is approximately 1% of
the total population.7,8 Both countries place
high value on patient autonomy in their legal
frameworks concerning end-of-life issues; for
example, both have specific laws on patient
rights,9,10 and a law on euthanasia,11,12 the first
worldwide. In both countries, palliative care has
been well developed and integrated within the
national health care system,13,14 and in a re-
cently published Quality of Death Index, which
measures the current end-of-life health care en-
vironment, availability, cost, and quality across
40 countries, Belgium and The Netherlands
ranked fifth and seventh,15 respectively.
Using an identical study design, we aimed to
address the following research questions
among a representative sample of terminally
ill patients:
1) What is the prevalence and what are
the characteristics of ACP within a non-
suddenly deceased population in Belgium
and The Netherlands?
2) Which patient and health care character-
istics are associated with the occurrence
of ACP?Methods
Study Design, Setting, and Participants
In Belgium and The Netherlands, we set up
a nationwide mortality follow-back study in
2007 aimedatmonitoring end-of-life care in col-
laboration with the national Sentinel Networks
of general practitioners (GPs) (SENTI-MELC
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nationwide surveillance of a wide variety of
health-related topics,16e22 with a turnover rate
that, from year to year, remains low. This means
that participating GPs did not enroll because of
specific interest in the field of end-of-life care.
The Belgian network covers 1.6% of the to-
tal patient population and is representative of
all GPs in the country in terms of age, gender,
and geographical distribution.19,23 The cover-
age in The Netherlands approximates to 1%
of the registered patient population, and the
network is nationally representative by gender,
age, geographical distribution, and popula-
tion density.24,25 The Belgian Scientific Insti-
tute of Public Health (IPH) and NIVEL
(The Netherlands Institute for Health Ser-
vices Research) acted as coordinators of the
respective national Sentinel Networks. In
2007, the Belgian network comprised 156 reg-
ularly participating practices, compared with
45 in The Netherlands.
Participating GPs register each death in
their practice of anyone aged one year or older
on a standardized form within a week of its oc-
currence.21 The GPs certify the deaths of their
patients themselves or are notified by the certi-
fying GP or hospital colleague after death. To
identify a sample of terminally ill patients
who could benefit the most from having an ad-
vance care plan, we asked the GP, ‘‘Was this
death sudden and totally unexpected?’’ Only
those patients whose death was non-sudden
and expected, as judged by the GP, were in-
cluded in this study. The design has been
used previously in several other studies on
end-of-life care and decision making.21,26e29
In Belgium, the study protocol and anonym-
ity procedures were approved by the Ethical
Review Board of the University Hospital of the
Vrije Universiteit Brussel. An approval from
the Ethical Review Board was not required for
this study in TheNetherlands because of the na-
ture of the data collection (post-mortem). In
both countries, patient anonymity was pre-
served and physician confidentiality main-
tained through the registration and data entry
processes.
Data Collection
The registration form comprised structured
closed-ended questions surveying sociodemo-
graphic patient information, the patient’splace of longest residence during the last
year of life, the place and cause of death,
and the GP’s appraisal as to whether or not
the patient was capable of making decisions
in the last three days of life.
A major part was aimed at measuring the ex-
istence and content of an advance care plan.
Definitions of ACP vary between countries
and studies. We based our question on Teno
et al.,1 who defined ACP as a process of com-
munication among patients, their health care
providers, their families, and important others
regarding the kind of care that will be consid-
ered appropriate when the patient is unable to
make decisions about his or her care. ACP in
this article covers a range of preferencesd
without being exhaustivedrelated to the with-
holding or withdrawal of potentially life-
prolonging procedures that are common in
end-of-life care decision making; it clarifies
preferences to receive certain care or treat-
ment rather than to have it withheld. We focus
not only on ACP made with patients them-
selves, but also on agreements about the pa-
tient’s situation that are made with the
patient’s family only.
In afirst set of questions,GPswere asked to in-
dicate whether or not they were aware of ‘‘a pre-
vious agreement, with the patient or his/her
family, not to initiate or to stoponeof the follow-
ing potentially life-prolonging treatments un-
der certain circumstances: chemotherapy,
artificial food administration, artificial fluid ad-
ministration, blood transfusion, artificial respi-
ration, cardiopulmonary resuscitation, dialysis,
antibiotics, vasopressors, and hospital transfer.’’
If yes, then GPs were asked to indicate whether
or not the agreement also was ‘‘made inwriting’’
(advance directive) and/or ‘‘made in consulta-
tion with the patient.’’ A second group of ques-
tions measured the GP’s knowledge of any
previous agreement with patient or family to
perform, under certain circumstances, the fol-
lowing medical practice: 1) an overall agree-
ment to forgo any potential life-prolonging
treatments (when testing the questionnaire,
some GPs indicated that patients do not always
plan for specific treatments but use more gen-
eral statements), 2) intensifying the alleviation
of pain and/or symptoms with a possible
life-shortening effect, 3) keeping the patient
unconscious until death using medication
with/without artificial feeding or hydration
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ing, supplying, or administering a drug with
the explicit intention of hastening the end of
life (physician-assisted death). If yes, GPs were
asked to indicate whether or not the agreement
was ‘‘made in writing’’ and/or ‘‘in consultation
with the patient.’’
Other care characteristics measured in-
cluded the following: whether or not GP con-
tacts with the patient or with relatives
concerning the patient had occurred during
the last week of life, whether or not a specialist
palliative care service had been involved within
the last three months of life, and the main
treatment goal in the last week of life (cure,
prolonging life, or comfort/palliation; in cases
in which the treatment goal had changed dur-
ing the last week, we relied on the GP’s judg-
ment to indicate the most important goal).
The wording of these questions was identical
to that used in previous research.27,28 The se-
lection of patient and health care characteris-
tics was based on their possible influence on
end-of-life care and communication in both
countries, as stated in previous research.6,26
Several procedures were used to ensure data
quality: the registration form was originally de-
veloped in Dutch, then translated via a forward-
backward procedure into French, as the study
covered both language regions of Belgium;
the study design was subjected to an extensive
pilot study in 200430 and was used in previous
registration years (2005 and 2006);21,26e29,31
the 2007 questionnaire was pretested by 10
GPs from each country for readability and com-
prehensibility; an automatic follow-up and tele-
phone contact with the GPs were used to
prevent missing data; and on data entry, the
registration forms were closely scrutinized for
errors, and several quality control measures
were used to ensure optimal data quality (e.g.,
data entry checking for consistency and
whether GPs followed the correct route in the
questionnaire).Analyses
We calculated the proportion of patients for
whom the GPs indicated thatdfor at least one
particular medical practicedthere was 1) an
advance care plan made in consultation with
patient, 2) an advance care plan made both
in consultation with the patient and in writing,and 3) a care plan made with the patient’s fam-
ily without consulting the patient.
With StatXact6 (Cytel, Inc., Cambridge,
MA), 95% confidence intervals (CIs) were cal-
culated on the percentages shown. SPSS 17.0
(SPSS Inc., Chicago, IL) and STATA 10 (Stata-
Corp LP, College Station, TX) were used for
other statistical computations: logistic regres-
sion analysis was used to explore bivariate
associations between patient/health care char-
acteristics and binary outcome measures. Vari-
ables that were significantly associated were
included in multivariate logistic regression
models to investigate their independent pre-
dictive value. Multilevel analyses (by means of
a marginal Generalized Estimating Equations
model) accounted for clustering of the data
by physician practices. If missing data for an in-
dependent variable were higher than 5% of
cases, these also were entered as a separate cat-
egory in the multivariate analyses to increase
statistical power of the model.Results
The Belgian and Dutch Sentinel GPs re-
ported 1191 and 520 deaths, respectively. Of
these 1711 deaths, 20 cases were excluded
because of too much missing data. Of all
remaining deaths, 63.4% were non-sudden
(n¼ 1072). In both countries, the characteris-
tics of the non-sudden deaths were compared
with those of a group of non-sudden deaths
identified in a nationwide, representative,
large-scale, death certificate study (for Belgium,
this covered only theDutch-speaking part). The
Belgian sample was representative for age, gen-
der, and place of death (n¼ 2128).32 In The
Netherlands, representativeness was reached
for age and gender. However, nursing home
deaths were underrepresented (n¼ 9965)33
(analyses not shown). The characteristics of
the study population are presented in Table 1.
An overview of the types and characteristics
of ACP within the total sample of terminally
ill patients is shown in Table 2. Advance agree-
ments about a medical practice were made
with 34% of patients. More specifically, per-
centages of ACP concerning the withholding
or withdrawing of a particular life-prolonging
treatment varied between 4% (about vasopres-
sors) and 20% (about hospital transfer).
Table 1
Characteristics of the Non-Sudden Deaths Studied in Belgium and The Netherlands
Characteristics
All Non-Sudden Deaths
(n¼ 1072)a Belgium (n¼ 755)
The Netherlands
(n¼ 317)
n % 95% CIb % %
Age at death
<65 years 176 16.8 (14.2e19.7) 15.9 19.0
65e79 years 313 29.9 (26.5e33.4) 29.2 31.6
$80 years 559 53.3 (49.6e57.1) 54.9 49.3
Gender
Male 489 46.5 (43.1e50.0) 45.3 49.7
Female 562 53.5 (50.0e46.9) 54.7 50.3
Level of educationc
Elementary or lower 419 44.5 (40.6e48.4) 42.2 50.4
Lower/higher secondary 427 45.4 (41.5e49.3) 48.6 37.3
Higher education/university 95 10.1 (7.9e12.6) 9.2 12.3
Capacity for decision making three days before
deathc,d
Totally incapable (worst case possible) 310 36.1 (32.2e40.1) 42.1 20.6
Not entirely capable 281 32.8 (29.0e36.7) 30.3 39.1
Capable of making decisions 267 31.1 (27.4e35.0) 27.6 40.3
Main treatment goal in the last week of lifec
Cure/prolonging life 188 18.8 (16.1e21.7) 22.7 8.6
Comfort/palliation 812 81.2 (78.3e83.9) 77.3 91.4
Specialist palliative care services usedc
Yes 348 33.2 (30.0e36.5) 38.3 21.2
No 700 66.8 (63.5e70.0) 61.7 78.8
Patient-GP contact during the last week of life
None 290 27.1 (24.1e30.2) 27.8 25.2
At least one 782 72.9 (69.8e76.0) 72.2 74.8
Cause of death
Malignancies 449 42.0 (38.0e46.0) 40.2 46.3
Cardiovascular disease 189 17.7 (14.7e20.9) 17.2 18.7
Respiratory disease 89 8.3 (6.3e10.8) 8.6 7.6
Disease of nervous system 50 4.7 (3.2e6.6) 4.5 5.1
Stroke 74 6.9 (5.0e9.2) 6.6 7.6
Other 218 20.4 (17.2e23.8) 22.8 14.6
Longest place of residence in last year
Home 750 72.5 (69.7e76.0) 71.5 75.2
Institutione 272 27.5 (24.0e30.3) 28.0 24.8
Elsewhere (n¼ 6)f
Place of deathc
Home 298 28.5 (25.1e32.1) 24.5 38.6
Hospital 382 36.5 (32.8e40.3) 39.0 30.2
Care home 271 25.9 (22.6e29.4) 25.3 27.4g
Palliative care unit/hospice 95 9.1 (7.0e11.5) 11.2 3.7
aMissing values <5% for age at death, gender, specialist palliative care services, patient-GP contact, cause of death, longest place of residence,
place of death; <10% for treatment goal; <15% for level of education; and 20% for decision-making capacity.
bMultinomial CIs, exact method.
cDifference between countries was significant at alpha 0.05 (Fisher’s exact test).
dScores could range from 0 to 10: capable of making decisions (score 0e4); not entirely capable (score 5e9); and totally incapable (score 10).
eFor Belgium: care homes (28.0%); for The Netherlands: residential homes for older people (22.9%) and nursing homes (1.9%).
fNot included in analysis.
gResidential homes for older people (19.3%) and nursing homes (8.1%).
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decision at the end of the patient’s life varied
a good deal between the different types of de-
cisions. The highest proportion was found for
an agreement made with patients about forgo-
ing any potentially life-prolonging treatment(24% of patients) followed by the decision to
intensify pain or symptom alleviation despite
a possible life-shortening effect (16%).
The GPs indicated that, in 8% of all non-
sudden deaths, a written advance agreement
wasmadewith thepatient.As such, theoutcomes
Table 2
Prevalence of Advance Care Planning (ACP) (n¼ 1072)a
Advance Care Planning (ACP)
ACP with Patient
ACP with Patient
and in Writing
Care Planning with
Family Only
% 95% CIb % 95% CIb % 95% CIb
Any type of ACP 33.6 (30.7e36.6) 7.7 (6.1e9.5) 22.7 (20.2e25.4)
ACP to withhold/withdraw
a potentially life-prolonging
treatment
26.2 (23.6e29.0) 3.6 (2.6e5.0) 18.4 (16.1e20.9)
Chemotherapy/radiotherapy 13.4 (11.4e15.7) 1.2 (0.6e2.0) 8.1 (6.5e9.9)
Artificial food administration 10.5 (8.7e12.5) 1.3 (0.7e2.2) 11.6 (9.7e13.7)
Artificial fluid administration 9.6 (7.9e11.6) 1.5 (0.9e2.5) 12.2 (10.3e14.3)
Blood transfusion 7.0 (5.5e8.7) 0.9 (0.4e1.6) 6.2 (4.9e7.9)
Artificial respiration 9.8 (8.1e11.8) 1.4 (0.8e2.4) 9.9 (8.1e11.9)
Cardiopulmonary resuscitation 13.0 (11.0e15.2) 1.7 (1.0e2.7) 13.3 (11.3e15.6)
Dialysis 6.8 (5.4e8.5) 0.8 (0.3e1.5) 6.9 (5.5e8.6)
Antibiotics 4.9 (3.7e6.4) 0.5 (0.2e1.1) 6.4 (5.0e8.1)
Vasopressors 3.6 (2.5e4.9) 0.6 (0.2e1.3) 6.0 (4.6e7.6)
Hospital transfer 19.7 (17.3e22.2) 2.2 (1.4e3.3) 12.9 (10.9e15.1)
ACP to perform a medical end-of-
life decision
27.2 (24.5e30.0) 6.3 (4.9e8.0) 20.6 (18.2e23.2)
Forgoing potential life-
prolonging treatments in
general
24.3 (21.7e27.0) 4.7 (3.5e6.2) 18.0 (15.8e20.5)
Intensifying pain/symptoms
alleviation with a possible life-
shortening effect
16.4 (14.2e18.8) 2.3 (1.5e3.4) 14.5 (12.4e16.8)
Continuous sedation with
artificial feeding or hydration
1.8 (1.1e2.8) 0.6 (0.2e1.3) 3.1 (2.1e4.3)
Continuous sedation without
artificial feeding and
hydration
3.9 (2.8e5.3) 0.9 (0.4e1.6) 3.6 (2.6e5.0)
Administration, prescription, or
supply of drugs with the
explicit intention of
shortening the patient’s life
5.5 (4.2e7.0) 3.4 (2.4e4.6) 1.2 (0.6e2.0)
aDenominator is all non-sudden deaths; 30 cases (2.8%) were excluded from all analyses on ACP as all the involved questions were left
unanswered.
bBinomial CI; exact method.
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patients with whom an ACP had been discussed
(not shown in table). Regarding most of the
treatments and decisions, a written advance
agreement was made with 1% or 2% of cases.
Comparatively speaking, ACP about forgoing
potential life-prolonging treatments in general
(5%)and about theuse of drugswith theexplicit
intention of shortening the patient’s life (3%)
were most often documented.
In 23% of cases, care planning was
made with the patient’s family without in-
volvement of the patient. Most agreements
concerned forgoing potential life-prolonging
treatments in general (18%), intensifying
the alleviation of pain or other symptoms de-
spite a possible life-shortening effect (15%),
cardiopulmonary resuscitation (13%), hospi-
tal transfer (13%), and artificial food or fluidadministration (12%). Agreements about
the use of drugs with the explicit intention
of shortening the patient’s life that were
made with the family occurred in 1% of
cases.
Multivariate analyses indicated that ACP was
more often made when patients had had con-
tact with their GP in the last week of life (three
times more often) (Table 3), when patients
were capable to some extent to make decisions
in the last three days of life as opposed to
totally incompetent patients (two to four
times), when treatment was aimed at palliation
as opposed to cure or the prolongation of life
during the last week of life (2.5 times), when
patients died from cancer as opposed to non-
cancer diseases (1.5 times), and when patients
died at home as opposed to in an institution
(two times).
Table 3
Factors Associated with the Prevalence of Advance Care Planning (ACP) (n¼ 1072)
Characteristics
ACP with Patient ACP with Patient and in Writing Care Planning with Family Only
%
OR (95% CI)
Bivariatea
OR (95% CI)
Multivariateb %
OR (95% CI)
Bivariatea
OR (95% CI)
Multivariateb %
OR (95% CI)
Bivariatea
OR (95% CI)
Multivariateb
Age at death
#64 years 33.3 Reference category d 11.9 Reference category Reference category 18.5 Reference category Reference category
65e79 years 38.4 1.25 (0.84e1.85) d 9.6 0.79 (0.43e1.44) 1.22 (0.60e2.50) 17.5 0.94 (0.58e1.54) 0.82 (0.48e1.40)
$80 years 30.1 0.86 (0.60e1.25) d 4.9 0.38 (0.21e0.70) 0.72 (0.33e1.57) 27.6 1.68 (1.09e2.59) 1.01 (0.61e1.66)
Gender
Male 36.8 Reference category Reference category 8.5 Reference category d 19.9 Reference category Reference category
Female 30.5 0.75 (0.58e0.98) 0.78 (0.60e1.02) 6.9 0.81 (0.51e1.28) d 25.7 1.40 (1.04e1.88) 1.17 (0.86e1.58)
Country
The
Netherlands
37.4 Reference category d 13.1 Reference category Reference category 16.1 Reference category Reference category
Belgium 32.0 0.79 (0.60e1.04) d 5.4 0.38 (0.24e0.60) 0.50 (0.26e0.98) 25.5 1.79 (1.26e2.53) 1.41 (0.91e2.18)
Level of
education
Elementary or
lower
29.4 Reference category Reference category 5.1 Reference category Reference category 22.3 Reference category d
Lower/higher
secondary
36.8 1.40 (1.04e1.87) 1.17 (0.81e1.69) 9.0 1.81 (1.04e3.16) 1.39 (0.71e2.70) 22.3 1.00 (0.72e1.39) d
Higher
education/
university
43.5 1.85 (1.16e2.94) 1.00 (0.62e1.61) 16.3 3.59 (1.77e7.28) 2.02 (0.93e4.39) 28.3 1.37 (0.82e2.29) d
Cause of death
Noncancer 24.3 Reference category Reference category 5.3 Reference category Reference category 27.1 Reference category Reference category
Cancer 46.7 2.73 (2.10e3.56) 1.46 (1.08e1.96) 11.1 2.24 (1.40e3.56) 0.81 (0.42e1.55) 16.9 0.55 (0.40e0.74) 0.60 (0.41e0.87)
Treatment goal
last week
Cure/
prolonging
life
14.8 Reference category Reference category 1.1 Reference category Reference category 13.1 Reference category Reference category
Comfort/
palliation
40.2 3.88 (2.52e5.98) 2.57 (1.58e4.17) 9.6 9.58 (2.33e39.37) 4.94 (1.16e20.98) 26.1 2.34 (1.48e3.69) 2.83 (1.74e4.60)
Capacity for
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Table 3
Continued
Characteristics
ACP with Patient ACP with Patient and in Writing Care Planning with Family Only
%
OR (95% CI)
Bivariatea
OR (95% CI)
Multivariateb %
OR (95% CI)
Bivariatea
OR (95% CI)
Multivariateb %
OR (95% CI)
Bivariatea
OR (95% CI)
Multivariateb
Totally
incapable
22.7 Reference category Reference category 4.9 Reference category Reference category 37.8 Reference category Reference category
Not entirely
capable
39.8 2.25 (1.57e3.23) 2.10 (1.37e3.19) 7.5 1.57 (0.79e3.11) 1.42 (0.71e2.84) 19.0 0.39 (0.18e0.41) 0.47 (0.32e0.71)
Capable of
making
decisions
55.9 4.31 (2.99e6.21) 3.86 (2.42e6.14) 14.1 3.15 (1.68e5.90) 2.08 (1.00e4.32) 14.1 0.27 (0.26e0.56) 0.33 (0.22e0.51)
Contacts in last
week of life
No 12.7 Reference category Reference category 1.8 Reference category Reference category 19.2 Reference category d
Yes 41.1 4.81 (3.28e7.05) 2.71 (1.66e4.41) 9.8 5.88 (2.35e14.70) 4.83 (1.38e16.97) 24.0 1.33 (0.95e1.87) d
Place of death
Institution 24.5 Reference category Reference category 4.7 Reference category Reference category 24.9 Reference category Reference category
Home 57.6 4.20 (3.15e5.60) 2.16 (1.53e3.03) 14.8 3.54 (2.21e5.68) 1.64 (0.94e2.86) 18.3 0.67 (0.48e0.95) 0.79 (0.54e1.15)
Specialist
palliative
care
initiative
used in last
three
months of
life
No 28.3 Reference category Reference category 5.2 Reference category Reference category 21.4 Reference category d
Yes 45.3 2.10 (1.60e2.75) 1.32 (0.97e1.79) 12.6 2.66 (1.67e4.25) 2.21 (1.31e3.72) 25.6 1.27 (0.93e1.72) d
aOR with 95% CIs from a logistic regression analysis (‘‘no ACP made in consultation with the patient,’’ ‘‘no ACP made both in writing and in consultation with the patient,’’ and ‘‘no care planning made with
the patient’s family without consulting the patient’’ as respective reference categories). Significant values (P # 0.05) are shown in bold print.
bOR with 95% CIs from a multivariate regression analysis (‘‘no ACP made in consultation with the patient,’’ ‘‘no ACP made both in writing and in consultation with the patient,’’ and ‘‘no care planning made
with the patient’s family without consulting the patient’’ as respective reference categories), performed for all bivariately tested significant associations; if missing data for an independent variable were higher
than 5% of cases (level of education, treatment goal, and decision-making capacity), these also were entered as a separate category in the regression model to increase statistical power (not shown in table).
Significant values (P # 0.05) are shown in bold print.
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tients in Belgium were half as likely to have
an ACP made in writing compared with those
in The Netherlands. Additionally, patients
had about five times more chance of having
a documented ACP when treatment was aimed
at palliation or when they had had contact with
their GP during the last week of life and dou-
ble the chance when specialist palliative care
initiatives had been delivered over the last
three months of life or when they were still
fully capable of making decisions in the last
three days of life.
Results of the multivariate analyses further
indicated that patient care was three times
more likely to be planned with the patient’s
family only (without consulting the patient)
in cases where treatment was aimed at pallia-
tion in the last week of life and, respectively,
three times and two times less likely if patients
remained competent until the end of life or
died of a noncancer disease.Discussion
In general, ACP on at least one medical
practice concerning the end of life occurred
with about one-third of all non-suddenly
deceased patients in Belgium and The
Netherlands and most often related to the
forgoing of potential life-prolonging treat-
ments in general. Only in a small part of
the sample was an ACP made in writing. For
a quarter of all patients, care had been
planned with the family without patient in-
volvement. The factors associated with the
outcome measures but varying according to
type of care planning were the following:
country, dying at home, dying of cancer, hav-
ing GP contacts within the last week of life,
being capable of decision making in the last
three days of life, having a palliative treat-
ment aim during the last week of life, and
the involvement of specialist palliative care
services within the last three months of life.
To our knowledge, this study is the first to
provide European data on the prevalence of
ACP within a robust terminally ill population,
irrespective of setting, country, or diagnosis.
This has been made possible by the use of an
identical and dependable methodology across
countries: a nationwide representative SentinelNetwork of GPs, each with a long history of reg-
istration research not selected on the basis of
a specific interest in end-of-life research.
Because the observation unit of this study was
the GP, knowledge of whether the patient had
an ACP was based on the report of the GP
only. However, several control mechanisms
were used to ensure reporting quality. Registra-
tions were made within a week after death to
limit recall bias as much as possible, and GPs
were generally instructed to use the patient’s
records while completing the form. However,
because detailed information concerning the
care provided is not always available from the
patient’s medical files (e.g., verbal agree-
ments), surveying GPs directly has an impor-
tant surplus value. We also took several
measures that contributed to the reliability of
data: the use of an identical jointly developed
and pretested questionnaire and strict research
procedures, such as data entry with consistency,
range, and skip checks. The surveyed sample of
non-sudden deaths is well representative of the
national population of non-sudden deaths by
age, gender, and place of death in the Dutch-
speaking part of Belgium and by age and
gender in The Netherlands. The lack of repre-
sentativeness for place of death in The Nether-
lands is a limitation resulting from an
underrepresentation of nursing home patients
because of the fact that nursing home physi-
cians take over the care from GPs once patients
are admitted for long-term care.34,35 Addition-
ally, because our reports were limited to the
perceptions of GPs, ACP done within a hospital
might not always have been fully communi-
cated to GPs.
Consequently, although representativeness
is reached for the general practice population
in both Belgium and The Netherlands, there
might be some underestimation of the preva-
lence of ACP for all non-sudden deaths in
both countries. This study has other limita-
tions as well. Because of the retrospective de-
sign of the study, a possible memory bias
could never be excluded. It also was not possi-
ble to explore cause and effect relationships,
only associations between characteristics and
the prevalence of ACP. Additionally, defini-
tions of ACP may vary between countries,
which makes comparison of results with previ-
ous studies difficult. Finally, the timing of the
agreement was not measured.
574 Vol. 42 No. 4 October 2011Meeussen et al.ACP is documented only in a small propor-
tion of patients but verbally occurs with many
more. This finding is in line with the prevailing
consensus in the present literature that ACP
may not be narrowed to the formulation of
a written advance directive but must be re-
garded as a continuous process of communica-
tion, of which a written declaration may be an
outcome.36 Nevertheless, to provide care in
correspondence with the patient’s wishes,
a written advance directive may be very impor-
tant when the decision making is urgent,
without time for consultation; to use as a foun-
dation for future updating and reviewing; or to
ensure continuity of caredend-of-life care
transitions occur rather frequently in Belgium
and The Netherlands.29,37 Furthermore, ACP
only has a legal status when it is made in
writing.
Possible reasons for the low prevalence are
that preferences may change, that physicians
prefer to remain free to act according to their
own medical judgment at the moment of deci-
sion making,38 or that ACP is seen as a social
process between physician and patient, and
documenting it formally is regarded as
unnecessary.39
Remarkably, ACP is documented consider-
ably more often in The Netherlands than in
Belgium, even after controlling for country dif-
ferences in patient or care characteristics. This
country-specific effectmight be rooted in a gen-
eral difference in medical culture between the
two countries, as physicians in The Netherlands
tend more toward the formalization of prac-
tices.40,41 Also, the political and societal debate
concerning euthanasia and other end-of-life de-
cisions has a longer history in The Netherlands
than in Belgium, and the Dutch Medical Treat-
ment Contracts Act,10 in which the importance
of the patient’s written authority for medical
treatments has to be made explicit to them,
has been in place several years longer than the
Belgian Law on Patient Rights.9 As a result, ad-
vance directive forms in The Netherlands
(widely promoted by the Dutch Association for
Voluntary Euthanasia) are more widespread
compared with Belgium, which also may be
part of the explanation.
However, compared with findings from the
United States (71% of nontraumatic deaths),
the prevalence of advance directives in both
our study samples remains very low.3 Also, inthe United Kingdom, a study concluded that
discussions related to ACP are very rarely initi-
ated among a group of chronically ill pa-
tients.42 It seems safe to suggest that advance
directives are still more prevalent in the
United States than in Europe. A reason for
this may be that advance directives have
a much longer tradition in the United States
and the fact that advance directives, which usu-
ally limit treatment, are considered more nec-
essary in the United States because American
physicians are more inclined to more aggres-
sive treatment options than their European
colleagues.43 Also, in most European coun-
tries, it is not compulsory for hospitals or nurs-
ing homes to inform admitted patients of their
right to draft a treatment directive, in contrast
to the United States, where studies have shown
that the prevalence of advance directive docu-
mentation in nursing home medical records
has increased significantly since the implemen-
tation of the Patient Self-Determination Act.44
The relatively high rate of care planning with
the family of the patients without the latter’s
involvement in our study also might reflect
these differences in legislation. This finding
was particularly surprising because in both
Belgium and The Netherlands, a great value
is being placed on patient autonomy in health
care as is the case in most Western countries.
Our results further show that cancer pa-
tients are more often involved in the process
of ACP than noncancer patients, as the oppo-
site is true for patient care planning that oc-
curs with family only. It is known that cancer
patients have a relatively more predictable dy-
ing course with often a short period of evident
decline at the very end compared with other
chronic diseases.45 This also might mean that
cancer patients may be more aware of the
life-threatening consequences of their disease
and thus possibly engage in ACP more proac-
tively compared with others.
Another key finding is that ACP relates
strongly to the provision of palliative care.
A core value of the palliative care philosophy
from its inception has been in enabling people
to make genuine choices about their own
care;46 this is very reconcilable with what is in-
tended by ACP. Although palliative care has
much to offer from the early stages of a pro-
gressive disease,47 previous research demon-
strated that palliative care is often initiated
Vol. 42 No. 4 October 2011 575ACP in Belgium and The Netherlandsrelatively close to death.26,48 This might sug-
gest that end-of-life care planning also is initi-
ated rather late in the dying process, when
death is imminent and end-of-life decision
making comes to the fore.
That end-of-life care agreements are rela-
tively oftenmadewithout consulting the patient
supports this thought, as it possibly means that
discussions about futuremedical care takeplace
at a time when the patient has already become
incompetent or is unable to express his/her
wishes and advice from family members is
needed, which is in line with our results. The
finding that many patients are unable to make
decisions at the very end of life points to the im-
portance of exploring patient wishes before-
hand so that physicians can take them into
account when making end-of-life decisions.
Also, the strong relationship between having
one or more GP consultations within the last
week of life and the chance of having made an
ACP might further suggest that ACP is initiated
and discussed at these late contacts, rather than
before. This may be because some GPs feel con-
strained timewise or are uncertain about when
to initiate end-of-life discussions.49e51 Previous
studies have shown that patients are more satis-
fied with their GP when advance directives are
discussed.49 Moreover, it could be a satisfactory
experience for the physician as well.52 Alto-
gether, the extent to which ACP truly occurs in
advance of future medical decision making is
questionable.
In conclusion, ACP is present in one-third of
the studied terminally ill patient population,
but these end-of-life care agreements are very
often left undocumented. This study supports
the idea that advance directives are more wide-
spread and prevalent in the United States than
in European countries, although differences
did occur between Belgium and The Nether-
lands as well. Our results further suggest that
ACP strongly relates to the provision of pallia-
tive care and that it is often done ad hoc in the
patient’s terminal phase of life rather than
earlier in the course of the illness. The high
rate of care planning with the family without
patient involvement further supports this
thought. Initiatives to encourage GPs to docu-
ment the ACP discussions and agreed out-
comes, and to do this in a timely fashion,
could assist to ensure that a person’s wishes
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